TY - JOUR
T1 - Trephination for primary pediatric pilonidal sinus disease
T2 - medium term functional and recurrence outcome of a large cohort
AU - Iacob, Catalin
AU - Niazov, Eleonora
AU - Zmora, Osnat
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024.
PY - 2025/12
Y1 - 2025/12
N2 - Purpose: Minimal incision procedures have been recommended for pediatric pilonidal sinus disease, based on small studies with short follow-up. We aimed to describe medium-term outcomes of trephination in a large cohort. Methods: Retrospective chart review and additional concluding telephone interviews for all children who underwent primary trephination in our institution over 5.5 years, collecting demographic and clinical data, and updated functional and recurrence outcome data. Results: 100 patients were included. Median follow-up time was 31.4 (16.2–52.8) months. Post-operative analgesics were used for 1.25 (0–4) days, sick days were 7 (3–11), and time to full activity was 14 (14–30) days. Recurrent pain, discharge, and abscess/es were reported by 37%, 35%, and 15% of patients, with 80–85% occurring within the first post-operative year. Reoperation rate was 18%, with 95% occurring within 2 years. No significant associations were found between demographic or clinical characteristics and either functional or recurrence medium-term outcomes. Conclusion: Trephination carries excellent functional outcome with less favorable medium-term efficacy for the treatment of primary pediatric pilonidal sinus disease. Most adverse outcomes, including reoperations, occur within the first two years.
AB - Purpose: Minimal incision procedures have been recommended for pediatric pilonidal sinus disease, based on small studies with short follow-up. We aimed to describe medium-term outcomes of trephination in a large cohort. Methods: Retrospective chart review and additional concluding telephone interviews for all children who underwent primary trephination in our institution over 5.5 years, collecting demographic and clinical data, and updated functional and recurrence outcome data. Results: 100 patients were included. Median follow-up time was 31.4 (16.2–52.8) months. Post-operative analgesics were used for 1.25 (0–4) days, sick days were 7 (3–11), and time to full activity was 14 (14–30) days. Recurrent pain, discharge, and abscess/es were reported by 37%, 35%, and 15% of patients, with 80–85% occurring within the first post-operative year. Reoperation rate was 18%, with 95% occurring within 2 years. No significant associations were found between demographic or clinical characteristics and either functional or recurrence medium-term outcomes. Conclusion: Trephination carries excellent functional outcome with less favorable medium-term efficacy for the treatment of primary pediatric pilonidal sinus disease. Most adverse outcomes, including reoperations, occur within the first two years.
KW - Medium-term outcome
KW - Pediatric
KW - Pilonidal
KW - Trephination
UR - http://www.scopus.com/inward/record.url?scp=85212764968&partnerID=8YFLogxK
U2 - 10.1007/s00383-024-05941-4
DO - 10.1007/s00383-024-05941-4
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 39708093
AN - SCOPUS:85212764968
SN - 0179-0358
VL - 41
JO - Pediatric Surgery International
JF - Pediatric Surgery International
IS - 1
M1 - 39
ER -